rdf:type |
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0021149,
umls-concept:C0030705,
umls-concept:C0185117,
umls-concept:C0220901,
umls-concept:C0237881,
umls-concept:C0439234,
umls-concept:C0750502,
umls-concept:C0806909,
umls-concept:C0936012,
umls-concept:C1413221,
umls-concept:C1514923,
umls-concept:C1522577,
umls-concept:C2911684
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-10-9
|
pubmed:abstractText |
The aim of this study was to evaluate the incidence of CD38 expression in all CLL patients of our institution and to determine its prognostic significance in correlation with other parameters of the disease.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0378-584X
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
437-41
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:17028452-Adult,
pubmed-meshheading:17028452-Antigens, CD38,
pubmed-meshheading:17028452-Female,
pubmed-meshheading:17028452-Follow-Up Studies,
pubmed-meshheading:17028452-Germany,
pubmed-meshheading:17028452-Humans,
pubmed-meshheading:17028452-Incidence,
pubmed-meshheading:17028452-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:17028452-Male,
pubmed-meshheading:17028452-Prognosis,
pubmed-meshheading:17028452-Reproducibility of Results,
pubmed-meshheading:17028452-Retrospective Studies,
pubmed-meshheading:17028452-Risk Assessment,
pubmed-meshheading:17028452-Risk Factors,
pubmed-meshheading:17028452-Sensitivity and Specificity,
pubmed-meshheading:17028452-Survival Analysis,
pubmed-meshheading:17028452-Survival Rate,
pubmed-meshheading:17028452-Tumor Markers, Biological
|
pubmed:year |
2006
|
pubmed:articleTitle |
Retrospective analysis of CD38 expression in 102 patients with B-CLL with a maximum follow-up of 18 years: incidence and prognostic significance.
|
pubmed:affiliation |
Medizinische Klinik II, Hämatologie und Onkologie, Klinikum Offenburg, Germany. dr.jakob@gmx.net
|
pubmed:publicationType |
Journal Article
|